Risk factors for visceral leishmaniasis: role of Epstein-Barr virus infection.
Louzir
H
H
Laboratoire d'Immunologie-Institut Pasteur de Tunis.
Triki
H
H
Bennani
S
S
Edelman
L
L
Laouini
D
D
Ben Ismail
R
R
Joab
I
I
Dellagi
K
K
D000208:Acute Disease; D000914:Antibodies, Viral / Q000097:blood*; D016022:Case-Control Studies; D002648:Child; D005260:Female; D006566:Herpesviridae Infections / Q000097:blood / Q000150:complications* / Q000453:epidemiology* / Q000276:immunology; D004854:Herpesvirus 4, Human / Q000276:immunology; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood*; D007075:Immunoglobulin M / Q000097:blood*; D007898:Leishmaniasis, Visceral / Q000150:complications* / Q000469:parasitology; D008297:Male; D016555:Matched-Pair Analysis; D012307:Risk Factors; D014412:Tumor Virus Infections / Q000097:blood / Q000150:complications* / Q000453:epidemiology* / Q000276:immunology
D000914:Antibodies, Viral; D007074:Immunoglobulin G; D007075:Immunoglobulin M